Syphilis

The rates of chlamydia and syphilis declined dramatically among individuals living with HIV who were prescribed doxycycline postexposure prophylaxis, according to results of a retrospective cohort study.

For the second year in a row, the CDC’s annual STI report showed an overall decline in combined cases of the three nationally reportable infections — chlamydia, gonorrhea and syphilis.

Throughout 2024, data surrounding STDs came in waves of good and bad news, with data showing slower rates of infection and even disease elimination intermingling with news of hospitals failing to follow CDC guidance.

Amid progress made on COVID-19 prevention and treatment and continued progress on ART for HIV, and new concerns about syphilis levels in the United States, updates to clinical guidance in 2024 covered a lot of ground.

Local health officials in the Democratic Republic of the Congo announced that dozens have died and hundreds more are sick due to an unknown illness that causes influenza-like symptoms.

Syphilis, an STI caused by the bacterium Treponema pallidum, has re-emerged as a major public health threat in the United States, with rates skyrocketing over the past decade.

After consuming organic carrots infected with Escherichia coli, one person has died and 15 people have been hospitalized in a multistate outbreak of the disease.

The U.S. Preventive Services Task Force released a draft recommendation encouraging physicians to screen for syphilis in people who are pregnant as early as possible.

NEW YORK — In this video, Jacob R. McLean, DO, assistant professor of medicine at Columbia University, recaps his presentation on adolescent STI screening and treatment at the Infectious Diseases in Children Symposium.

Although reported cases remain high, there are signs the STI epidemic in the United States is slowing after years of record numbers, the CDC said Tuesday.